Correspondence 0001104659-23-076591 from Magnum Opus Acquisition Ltd (CIK 0001843121)
Magnum Opus Acquisition Ltd (CIK 0001843121)
Date: June 30, 2023 · CIK: 0001843121 · Accession: 0001104659-23-076591
AI Filing Summary & Sentiment
File numbers found in text: 001-40266
Referenced dates: June 29, 2023
Show Raw Text
CORRESP
1
filename1.htm
June 30, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Technology
100 F Street, NE
Washington, D.C. 20549
Attention: Lauren Pierce and Kathleen Krebs
Re: Magnum Opus Acquisition Ltd
Preliminary Proxy Statement on Schedule 14A Filed June 16, 2023
File No. 001-40266
Ladies and Gentlemen:
On behalf of our client, Magnum Opus Acquisition
Limited (the “Company”), this letter sets forth responses of the Company to the comments of the staff of the Division
of Corporation Finance (the “Staff”) of the Securities and Exchange Commission (the “Commission”)
set forth in your letter dated June 29, 2023, with respect to the above referenced preliminary proxy statement on Schedule 14A filed June
16, 2023 (the “Proxy Statement”).
In order to facilitate your review of our responses,
we have restated each of the Staff’s comments in this letter, and we have numbered the paragraphs below to correspond to the numbers
in the Staff’s letter. For your convenience, we have also set forth the Company’s responses to each of the Staff’s comments
immediately below the corresponding numbered comment.
In addition, the Company has revised the Proxy
Statement in response to the Staff’s comments and is filing Amendment to the Proxy Statement on Schedule 14A (the “Amended
Proxy Statement”) concurrently with this letter, which reflects these revisions and clarifies certain other information. Page
numbers in the text of the Company’s responses correspond to page numbers in the Amended Proxy Statement. Unless otherwise indicated,
capitalized terms used herein have the meanings assigned to them in the Amended Proxy Statement.
Proxy Statement on Schedule 14A filed June 16, 2023
Questions and Answers About the Extraordinary Meeting
How do the Company insiders intend to vote their shares? page 7
1. We note that the sponsor or its affiliates may purchase public shares in privately negotiated transactions or in the open market and
your disclosure that “[a]ny public shares held by or subsequently purchased by our affiliates may be voted in favor of the Extension
Amendment Proposal.” Please explain how such purchases would comply with the requirements of Rule 14e-5 under the Exchange Act.
Refer to Tender Offer Rules and Schedules Compliance and Disclosure Interpretation 166.01 for guidance.
United States Securities and Exchange Commission
June 30, 2023
Response: The Company acknowledges
the Staff’s comment and has revised the disclosure on pages 7 and 41 of the Amended Proxy Statement accordingly.
General
2. We note that your Investment Management Trust Agreement with Continental Stock Transfer & Trust Co. appears to be effective through
July 25, 2023 only. Section 102.06 of the NYSE Listed Company Manual states that “at least 90% of the proceeds ... will be held
in a trust account controlled by an independent custodian until consummation of a business combination.” It is unclear whether the
custodianship of your trust account comports with this listing standard. Please revise your disclosure or tell us how this provision complies
with Section 102.06.
Response: The Company respectfully
advises the Staff that (a) pursuant to Section 1(a) of the Amended and Restated Investment
Management Trust Agreement dated March 17, 2023 (the “Amended and Restated Investment Management and Trust Agreement”), Continental
Stock Transfer & Trust Company, as the Trustee (the “Trustee”), has agreed, among other things, to hold the gross
proceeds of the IPO (and any interest subsequently earned thereon) in trust in accordance with the terms of the Amended and Restated Investment
Management and Trust Agreement in the Trust Account: (b) pursuant to Section 1(i)(y) of the Amended and Restated Investment Management
and Trust Agreement, the Trust Account shall be liquidated “upon the date which is the later of (1) April 25, 2023; (2) such later
date upon the Extension effectuated pursuant to the terms hereof; and (3) such later date as may be approved by the Company’s shareholders
in accordance with the Company’s amended and restated memorandum and articles of association if a Termination Letter has not been
received by the Trustee prior to such date; ” and (c) Section 5(b) of the Amended and Restated Investment Management Trust Agreement
provides that the Amended and Restated Investment Management Trust Agreement shall terminate “[a]t such time that the Trustee has
completed the liquidation of the Trust Account and its obligations in accordance with the provisions of Section 1(i) hereof and distributed
the Property in accordance with the provisions of the Termination Letter.” The effectiveness of the Investment Management and Trust
Agreement is therefore not through July 25, 2023 only, but rather the later of July 25, 2023 and “such later date as may be approved
by the Company’s shareholders,” including through voting at the Extraordinary Meeting which is the subject of this proxy statement.
The form of the Amended and Restated Investment Management and Trust Agreement was included as Annex C in the proxy statement on Schedule
14A filed by the Company on February 17, 2023. The Amended and Restated Investment Management and Trust Agreement was entered into by
and between the Company and the Trustee on March 17, 2023, following the approval of the Company’s shareholders at an extraordinary
general meeting of shareholders held on March 17, 2023, and filed as Exhibit 10.1 to a Current Report
on Form 8-K filed by the Company on March 21, 2023. No further amendment to the Amended and Restated Investment Management and
Trust Agreement is required, nor is any being proposed, in connection with this proxy statement. In light of the above, the Company respectfully
advises the Staff that the custodianship of its Trust Account does comport with Section 102.06 of the NYSE Listed Company Manual.
We hope that the foregoing has been responsive
to the Staff’s comments. Please do not hesitate to contact Joel L. Rubinstein at (212) 819-764 White & Case LLP with any questions
or comments regarding this letter.
United States Securities and Exchange Commission
June 30, 2023
Sincerely,
/s/ White & Case LLP
White & Case LLP
cc: Jonathan Lin, Magnum Opus Acquisition Limited